Literature DB >> 12023057

The association of cholecystokinin-A receptor expression with the responsiveness of electroacupuncture analgesic effects in rat.

Giseog Lee1, Samwoong Rho, Minkyu Shin, Moochang Hong, Byung il Min, Hyunsu Bae.   

Abstract

The purpose of this study is to determine whether the level of cholecystokinin (CCK) receptor expression causes the differences between the responder and non-responder to electroacupuncture mediated analgesic effects. Male Sprague-Dawley rats were stimulated at the Zusanli (ST36) acupoint in the absence of any anesthetics and holders. The tail flick latency test was performed to quantify analgesic effects and then the responder and non-responder groups were classified. The hypothalamus of each group was dissected and RNA was purified. The amount of mRNA expression of CCK-A and CCK-B receptors was determined by reverse transcription-polymerase chain reaction. The results show that CCK-A receptors are significantly more expressed in non-responders than responders, whereas CCK-B receptor expression is similar in both groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023057     DOI: 10.1016/s0304-3940(02)00214-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Mechanisms of acupuncture-electroacupuncture on persistent pain.

Authors:  Ruixin Zhang; Lixing Lao; Ke Ren; Brian M Berman
Journal:  Anesthesiology       Date:  2014-02       Impact factor: 7.892

2.  Electroacupuncture modulation of reflex hypertension in rats: role of cholecystokinin octapeptide.

Authors:  Min Li; Stephanie C Tjen-A-Looi; Zhi-Ling Guo; John C Longhurst
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-19       Impact factor: 3.619

3.  [Is the analgesic effect of acupuncture a placebo effect?].

Authors:  F Musial; I Tao; G Dobos
Journal:  Schmerz       Date:  2009-08       Impact factor: 1.107

Review 4.  Acupuncture's Cardiovascular Actions: A Mechanistic Perspective.

Authors:  John Longhurst
Journal:  Med Acupunct       Date:  2013-04

5.  Differences in neural-immune gene expression response in rat spinal dorsal horn correlates with variations in electroacupuncture analgesia.

Authors:  Ke Wang; Rong Zhang; Xiaohui Xiang; Fei He; Libo Lin; Xingjie Ping; Lei Yu; Jisheng Han; Guoping Zhao; Qinghua Zhang; Cailian Cui
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

6.  Electroacupuncture Analgesia Is Improved by Adenoviral Gene Transfer of Dopamine Beta-hydroxylase into the Hypothalamus of Rats.

Authors:  Soo-Jeong Kim; Eun Sook Chung; Jun-Ho Lee; Chang Hoon Lee; Sun Kwang Kim; Hye-Jung Lee; Hyunsu Bae
Journal:  Korean J Physiol Pharmacol       Date:  2013-12-16       Impact factor: 2.016

7.  Expression levels of the hypothalamic AMPK gene determines the responsiveness of the rats to electroacupuncture-induced analgesia.

Authors:  Sun Kwang Kim; Boram Sun; Heera Yoon; Ji Hwan Lee; Giseog Lee; Sung-Hwa Sohn; Hyunseong Kim; Fu Shi Quan; Insop Shim; Joohun Ha; Byung-Il Min; Hyunsu Bae
Journal:  BMC Complement Altern Med       Date:  2014-06-30       Impact factor: 3.659

Review 8.  What intrinsic factors influence responsiveness to acupuncture in pain?: a review of pre-clinical studies that used responder analysis.

Authors:  Yu-Kang Kim; Ji-Yeun Park; Seung-Nam Kim; Mijung Yeom; Seungmin Lee; Ju-Young Oh; Hyangsook Lee; Younbyoung Chae; Dae-Hyun Hahm; Hi-Joon Park
Journal:  BMC Complement Altern Med       Date:  2017-05-25       Impact factor: 3.659

Review 9.  The neurobiology of pain and facial movements in rodents: Clinical applications and current research.

Authors:  Adriana Domínguez-Oliva; Daniel Mota-Rojas; Ismael Hernández-Avalos; Patricia Mora-Medina; Adriana Olmos-Hernández; Antonio Verduzco-Mendoza; Alejandro Casas-Alvarado; Alexandra L Whittaker
Journal:  Front Vet Sci       Date:  2022-09-29

10.  Mechanisms of electroacupuncture-induced analgesia on neuropathic pain in animal model.

Authors:  Woojin Kim; Sun Kwang Kim; Byung-Il Min
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.